The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP
- PMID: 19477175
- DOI: 10.1016/j.expneurol.2009.05.023
The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP
Abstract
Experimental traumatic brain injury (TBI) leads to a rapid and extensive necrosis at the primary site of injury that appears to be driven in part by significant mitochondrial dysfunction. The present study is based on the hypothesis that TBI-induced, aberrant glutamate release increases mitochondrial Ca(2+) cycling/overload ultimately leading to mitochondrial damage. Previous work from our laboratory demonstrates that mitochondrial uncoupling during the acute phases of TBI-induced excitotoxicity can reduce mitochondrial Ca(2+) uptake (cycling), ROS production and mitochondrial damage resulting in neuroprotection and improved behavioral outcome. The current study was designed to determine the optimal dosage and therapeutic window of opportunity for the potent mitochondrial uncoupler FCCP following moderate TBI. For this study, we used young adult male Sprague-Dawley rats (300-350 g); either sham-operated or moderately (1.5 mm) injured using the controlled cortical impactor (CCI) model of TBI. In the first set of studies animals were injected with either vehicle (100% DMSO) or different concentrations of FCCP (0.5, 1, 2.5 and 5 mg/kg in 100% DMSO) intraperitoneally at 5 min post-injury; tested behaviorally at 10 days and cortical sparing assessed at 18 days post-injury. The results demonstrate that of all the dosages tested, 2.5 mg/kg rendered the maximum improvement in behavioral outcomes and tissue spared. Using this optimal dose (2.5 mg/kg) and time point for intervention (5 min post-injury), we assessed mitochondrial bioenergetics and mitochondrial structural integrity 24 h post-injury. Furthermore, using this dosage we assessed mitochondrial bioenergetics and Ca(2+) loading at 3 and 6 h post-injury to further verify our target mechanism and establish these assessments as a valid endpoint to use as a means to determine the therapeutic window of FCCP. To begin to address the window of opportunity for maintaining mitochondrial homeostasis, the optimal dose of FCCP was then administered at 5 min, 3, 6, or 24 h post-injury and several parameters of mitochondrial function were used as outcome measures. The results demonstrate that a prolonged window of opportunity exists for targeting mitochondrial dysfunction using uncouplers following TBI and give insight into the cellular pathology associated with TBI.
Similar articles
-
Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents.J Neurotrauma. 2007 May;24(5):798-811. doi: 10.1089/neu.2006.3673. J Neurotrauma. 2007. PMID: 17518535
-
Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.Exp Neurol. 1999 Nov;160(1):226-34. doi: 10.1006/exnr.1999.7197. Exp Neurol. 1999. PMID: 10630207
-
Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury.Exp Neurol. 2000 Feb;161(2):631-7. doi: 10.1006/exnr.1999.7282. Exp Neurol. 2000. PMID: 10686082
-
Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?J Neurosci Res. 2005 Jan 1-15;79(1-2):231-9. doi: 10.1002/jnr.20292. J Neurosci Res. 2005. PMID: 15573402 Review.
-
Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury.J Neurochem. 2004 Oct;91(2):257-62. doi: 10.1111/j.1471-4159.2004.02736.x. J Neurochem. 2004. PMID: 15447659 Review.
Cited by
-
Oxidative metabolism alterations in the emotional brain of anxiety-prone rats.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109706. doi: 10.1016/j.pnpbp.2019.109706. Epub 2019 Jul 19. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 31330216 Free PMC article.
-
Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.Exp Neurol. 2020 Jul;329:113309. doi: 10.1016/j.expneurol.2020.113309. Epub 2020 Apr 11. Exp Neurol. 2020. PMID: 32289315 Free PMC article. Review.
-
Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation.Mol Neurobiol. 2013 Feb;47(1):9-23. doi: 10.1007/s12035-012-8344-z. Epub 2012 Sep 26. Mol Neurobiol. 2013. PMID: 23011809 Free PMC article. Review.
-
Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI).PLoS One. 2016 Jun 10;11(6):e0157064. doi: 10.1371/journal.pone.0157064. eCollection 2016. PLoS One. 2016. PMID: 27285176 Free PMC article.
-
N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI.Exp Neurol. 2014 Jul;257:106-13. doi: 10.1016/j.expneurol.2014.04.020. Epub 2014 May 1. Exp Neurol. 2014. PMID: 24792639 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous